Although larger tumor size, pT stage, and Fuhrman grade were previously reported as poor prognostic factors [32,33], this is the first study to show that mutations in ND1 were predictors of recurrence in localized RCC. This evidence concerns the gene MT-ND1 and renal cell carcinoma.